VivoSim Labs, Inc. Revenue, Net (Deprecated 2018-01-31)
VivoSim Labs, Inc. (VIVS) reported Revenue, Net (Deprecated 2018-01-31) of $3.63 million for the 12-month period ending 2018-03-31, per its 10-K filed 2018-05-31.
Discontinued › Income Statement › Revenue
us-gaap:SalesRevenueNet · last filed 2018-05-31
- VivoSim Labs, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $905.00K, a 17.38% increase year-over-year.
- VivoSim Labs, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $832.00K, a 19.03% increase year-over-year.
- VivoSim Labs, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $946.00K, a 7.53% decline year-over-year.
- VivoSim Labs, Inc. revenue, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $944.00K, a 40.06% increase year-over-year.
- VivoSim Labs, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2018 was $3.63M, a 14.52% increase from fiscal 2017.
- VivoSim Labs, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2017 was $3.17M, a 292.93% increase from fiscal 2016.
- VivoSim Labs, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2016 was $806.00K, a 156.69% increase from fiscal 2015.
- VivoSim Labs, Inc. revenue, net (deprecated 2018-01-31) for fiscal 2015 was $314.00K.
| Period end | Revenue, Net (Deprecated 2018-01-31) 3 month | Revenue, Net (Deprecated 2018-01-31) 6 month | Revenue, Net (Deprecated 2018-01-31) 9 month | Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2018-03-31 | $905.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-31 | $1.74M derived: sum of 2 quarters · filed 2018-05-31 | $2.68M derived: sum of 3 quarters · filed 2018-05-31 | $3.63M 10-K · filed 2018-05-31 |
| 2017-12-31 | $832.00K 10-Q · filed 2018-02-08 | $1.78M derived: sum of 2 quarters · filed 2018-02-08 | $2.72M 10-Q · filed 2018-02-08 | $3.49M derived: sum of 4 quarters · filed 2018-05-31 |
| 2017-09-30 | $946.00K 10-Q · filed 2017-11-09 | $1.89M 10-Q · filed 2017-11-09 | $2.66M derived: sum of 3 quarters · filed 2018-05-31 | $3.36M derived: sum of 4 quarters · filed 2018-05-31 |
| 2017-06-30 | $944.00K 10-Q · filed 2017-08-09 | $1.72M derived: sum of 2 quarters · filed 2018-05-31 | $2.41M derived: sum of 3 quarters · filed 2018-05-31 | $3.44M derived: sum of 4 quarters · filed 2018-05-31 |
| 2017-03-31 | $771.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-31 | $1.47M derived: sum of 2 quarters · filed 2018-05-31 | $2.49M derived: sum of 3 quarters · filed 2018-05-31 | $3.17M 10-K · filed 2018-05-31 |
| 2016-12-31 | $699.00K 10-Q · filed 2018-02-08 | $1.72M derived: sum of 2 quarters · filed 2018-02-08 | $2.40M 10-Q · filed 2018-02-08 | $2.51M derived: sum of 4 quarters · filed 2018-05-31 |
| 2016-09-30 | $1.02M 10-Q · filed 2017-11-09 | $1.70M 10-Q · filed 2017-11-09 | $1.81M derived: sum of 3 quarters · filed 2018-05-31 | $2.11M derived: sum of 4 quarters · filed 2018-05-31 |
| 2016-06-30 | $674.00K 10-Q · filed 2017-08-09 | $791.00K derived: sum of 2 quarters · filed 2018-05-31 | $1.08M derived: sum of 3 quarters · filed 2018-05-31 | $1.27M derived: sum of 4 quarters · filed 2018-05-31 |
| 2016-03-31 | $117.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-05-31 | $410.00K derived: sum of 2 quarters · filed 2018-05-31 | $597.00K derived: sum of 3 quarters · filed 2018-05-31 | $806.00K 10-K · filed 2018-05-31 |
| 2015-12-31 | $293.00K 10-Q · filed 2017-02-09 | $480.00K derived: sum of 2 quarters · filed 2017-02-09 | $689.00K 10-Q · filed 2017-02-09 | $864.00K derived: sum of 4 quarters · filed 2017-06-07 |
| 2015-09-30 | $187.00K 10-Q · filed 2016-11-03 | $396.00K 10-Q · filed 2016-11-03 | $571.00K derived: sum of 3 quarters · filed 2017-06-07 | $710.00K derived: sum of 4 quarters · filed 2017-06-07 |
| 2015-06-30 | $209.00K 10-Q · filed 2016-08-04 | $384.00K derived: sum of 2 quarters · filed 2017-06-07 | $523.00K derived: sum of 3 quarters · filed 2017-06-07 | $523.00K derived: sum of 4 quarters · filed 2017-06-07 |
| 2015-03-31 | $175.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-07 | $314.00K derived: sum of 2 quarters · filed 2017-06-07 | $314.00K derived: sum of 3 quarters · filed 2017-06-07 | $314.00K 10-K · filed 2017-06-07 |
| 2014-12-31 | $139.00K 10-Q · filed 2016-02-08 | $139.00K derived: sum of 2 quarters · filed 2016-02-08 | $139.00K 10-Q · filed 2016-02-08 | |
| 2014-09-30 | $0.00 10-Q · filed 2015-11-09 | $0.00 10-Q · filed 2015-11-09 | ||
| 2014-06-30 | $0.00 10-Q · filed 2015-08-10 | |||
| 2014-03-31 | $0.00 10-K · filed 2016-06-09 | |||
| 2013-03-31 | $0.00 10-K · filed 2015-06-09 | |||
| 2012-12-31 | $0.00 10-K · filed 2015-06-09 | |||
| 2012-03-31 | $0.00 10-K · filed 2015-06-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |